Evidence map›Paper›PMID 41590472›Full record

ArticleJournal of fungi (Basel, Switzerland)2026

Advancing the Identification of Risk Factors for Invasive Fungal Disease in Children with Cancer.

Marlon Barraza, Romina Valenzuela, Valentina Gutiérrez, Claudia Greppi, Ana M Álvarez, Jaime Cerda, María Elena Santolaya

Abstract read
In one paragraph

Article in Journal of fungi (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Fungal Infections in Pediatric Patients With Hematologic Malignancies and Stem Cell Transplantation: Impact on the Upper and Lower Respiratory Systems.The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Marlon BarrazaDepartment of Clinical Pharmacy, Hospital Dr. Luis Calvo Mackenna, Santiago 8010037, Chile.ORCID 0009-0005-7909-9289
Romina ValenzuelaDepartment of Pediatrics, Centro de Investigación Clínica Avanzada (CICA), Hospital Dr. Luis Calvo Mackenna, Faculty of Medicine, Universidad de Chile, Santiago 8010037, Chile.ORCID 0000-0001-9725-7686
Valentina GutiérrezDepartment of Pediatric Infectious Diseases and Immunology, Hospital Dr. Sótero del Río, School of Medicine, Pontificia Universidad Católica de Chile, Santiago 8010037, Chile.ORCID 0000-0002-5815-5035
Claudia GreppiCommittee of Infectious Diseases, National Child Program of Antineoplastic Drugs (PINDA), Santiago 8010037, Chile.
Ana M ÁlvarezCommittee of Infectious Diseases, National Child Program of Antineoplastic Drugs (PINDA), Santiago 8010037, Chile.
Jaime CerdaSchool of Medicine, Pontificia Universidad Católica de Chile, Santiago 8010037, Chile.ORCID 0000-0003-3463-8304
María Elena SantolayaDepartment of Pediatrics, Centro de Investigación Clínica Avanzada (CICA), Hospital Dr. Luis Calvo Mackenna, Faculty of Medicine, Universidad de Chile, Santiago 8010037, Chile.

Funding

Fondo Nacional de Desarrollo Científico y Tecnológico 1161662
6 · The paper itself

Abstract

Invasive fungal disease (IFD) is one of the leading causes of morbidity and mortality in immunocompromised pediatric patients. This is a multicenter prospective cohort study with a nested retrospective analysis aimed at identifying risk factors for IFD in immunocompromised children with cancer and episodes of persistent high-risk febrile neutropenia (HRFN). One hundred and seventy-four episodes of persistent HRFN were analyzed, of which 34 (19.5%) were confirmed as IFD, 52.9% were caused by filamentous fungi, and 47.1% by yeasts. Logistic regression and survival analyses identified the following significant risk factors for IFD: male sex (OR 4.04), adolescence (OR 4.65), C-reactive protein ≥ 90 mg/L at admission (OR 3.13), and transfer to a critical care unit (OR 10.73). The predictive model demonstrated strong discriminatory capacity (AUC 0.84), with 79.4% sensitivity and 82.1% specificity. These findings highlight that adolescents, particularly males with severe clinical conditions and elevated inflammatory markers, are at the highest risk for IFD during episodes of HRFN. The proposed risk factor-based model may support early risk stratification and guide targeted antifungal prophylaxis or therapy, potentially improving outcomes in this population. Validation an external cohort is required to confirm these results and optimize clinical applicability.

Indexed as

cancerchildreninvasive fungal infectionneutropeniarisk factors

Identifiers

PMID41590472
PMCPMC12843162

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.